Ubs Group Ag ADIAL PHARMACEUTICALS INC Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025
Number of Shares
12,395
Previous 47,745 74.04%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
SELL
N/A
-35,350 Reduced 74.04%
12,395 $0
Q1 2025

May 13, 2025
BUY
N/A
26,727 Added 127.16%
47,745 $0
Q4 2024

Feb 14, 2025
BUY
N/A
16,614 Added 377.25%
21,018 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-79,201 Reduced 94.73%
4,404 $0
Q2 2024

Aug 13, 2024
BUY
N/A
77,879 Added 1360.09%
83,605 $0
Q1 2024

May 13, 2024
BUY
N/A
2,104 Added 58.09%
5,726 $0
Q4 2023

Feb 09, 2024
BUY
N/A
3,076 Added 563.37%
3,622 $0
Q3 2023

Nov 09, 2023
BUY
N/A
546 New
546 $0
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email